MedPath

Arstasis, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Access Safety and Efficacy Post Endovascular Intervention

Not Applicable
Conditions
Cardiovascular Disease.
Interventions
Device: Arstasis Access System (AXERA)
First Posted Date
2013-01-23
Last Posted Date
2015-02-24
Lead Sponsor
Arstasis, Inc.
Target Recruit Count
240
Registration Number
NCT01773148
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Heart Center Research, LLC, Huntsville, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arkansas Heart Hospital, Little Rock, Arkansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Scripps Green, La Jolla, California, United States

and more 14 locations

A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System

Not Applicable
Completed
Conditions
Diagnostic Catheterization Access Through a 5F or 6F Femoral Artery Introducer
Interventions
Device: Diagnostic catheterization procedure
First Posted Date
2011-01-07
Last Posted Date
2013-01-31
Lead Sponsor
Arstasis, Inc.
Target Recruit Count
351
Registration Number
NCT01271946
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cardiovascular Institute of the South-Opelousas, Opelousas, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Cooper Health System, Camden, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

Volunteer Research Group, LLC, Knoxville, Tennessee, United States

and more 5 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath